April 28 — Moderna Inc (MRNA.O) said on Thursday it asked US regulators to authorize its COVID-19 vaccine for children under the age of 6, which would make it the first shot against the coronavirus available for those under 5-years-old.The COVID-19 vaccine from Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) is authorized for children 5 and older. But their trial results for 2- to 4-year-olds showed a weaker immune response than in adults, forcing the study to be extended to test a third dose. Pfizer has said that data would come in April.“This does represent an important area of unmet need,” Moderna Chief Medical Officer Paul Burton said in an interview.
Load More
Load More